Outpatient Randomized Controlled Trials in the Covid-19 Era and Beyond.

Jean M Connors,Maria M Brooks,Frank C Sciurba,Jerry A Krishnan,Joseph R Bledsoe,Lauren Castro,Heather Eng,Eileen Handberg,Peter C Hou, Joshua Hulbert,Bridget-Anne Kirwan,Janet Y Lin,Deborah Martin, Harriet Samuelson,Nancy L Shapiro,Elaine Zaharris,Steve R Wisniewski,Paul M Ridker

NEJM Evidence（2022）

引用 0|浏览5

暂无评分

摘要

Outpatient Trials in the Covid-19 Era and BeyondA group of investigators had a meeting at the National Heart, Lung, and Blood Institute in May 2020 to discuss ways to decrease thrombotic complications among symptomatic outpatients with Covid-19. The investigators discuss their approach to three specific challenges: conducting a trial remotely, working through regulatory hurdles, and recruiting a diverse population of participants.

查看译文

关键词

trials

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要